- Home
- MTEX vs TXMD Comparison
MTEX vs TXMD Comparison
Compare MTEX & TXMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MTEX
- TXMD
- Stock Information
- Founded
- MTEX 1993
- TXMD 2008
- Country
- MTEX United States
- TXMD United States
- Employees
- MTEX N/A
- TXMD N/A
- Industry
- MTEX Medicinal Chemicals and Botanical Products
- TXMD Biotechnology: Pharmaceutical Preparations
- Sector
- MTEX Health Care
- TXMD Health Care
- Exchange
- MTEX Nasdaq
- TXMD Nasdaq
- Market Cap
- MTEX 20.0M
- TXMD 17.1M
- IPO Year
- MTEX 1999
- TXMD N/A
- Fundamental
- Price
- MTEX $9.27
- TXMD $1.09
- Analyst Decision
- MTEX
- TXMD
- Analyst Count
- MTEX 0
- TXMD 0
- Target Price
- MTEX N/A
- TXMD N/A
- AVG Volume (30 Days)
- MTEX 3.1K
- TXMD 66.5K
- Earning Date
- MTEX 08-12-2025
- TXMD 08-11-2025
- Dividend Yield
- MTEX N/A
- TXMD N/A
- EPS Growth
- MTEX N/A
- TXMD N/A
- EPS
- MTEX N/A
- TXMD N/A
- Revenue
- MTEX $115,036,000.00
- TXMD $1,841,000.00
- Revenue This Year
- MTEX N/A
- TXMD $427.09
- Revenue Next Year
- MTEX N/A
- TXMD N/A
- P/E Ratio
- MTEX N/A
- TXMD N/A
- Revenue Growth
- MTEX N/A
- TXMD 53.55
- 52 Week Low
- MTEX $6.75
- TXMD $0.70
- 52 Week High
- MTEX $16.49
- TXMD $2.44
- Technical
- Relative Strength Index (RSI)
- MTEX 43.15
- TXMD 38.09
- Support Level
- MTEX $9.15
- TXMD $1.07
- Resistance Level
- MTEX $11.36
- TXMD $1.22
- Average True Range (ATR)
- MTEX 0.66
- TXMD 0.13
- MACD
- MTEX -0.13
- TXMD -0.02
- Stochastic Oscillator
- MTEX 21.72
- TXMD 19.15
About MTEX Mannatech Incorporated
Mannatech Inc is a wellness solution provider. The company develops and sells nutritional supplements, topical and skin care and anti-aging products, and weight-management products that target optimal health and wellness. Mannatech sells products in three regions: the Americas (the United States, Canada, and Mexico); Europe/the Middle East/Africa (EMEA) (Austria, the Czech Republic, Denmark, Estonia, Finland, Germany, the Republic of Ireland, Namibia, the Netherlands, Norway, South Africa, Spain, Sweden, and the United Kingdom); and Asia/Pacific (Australia, Japan, New Zealand, the Republic of Korea, Singapore, Taiwan, Hong Kong, and China). Mannatech generates the majority of its revenue from the Americas.
About TXMD TherapeuticsMD Inc.
TherapeuticsMD Inc is a pharmaceutical royalty company, currently receiving royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company and its subsidiaries (i) granted Mayne Pharma an exclusive license to commercialize its IMVEXXY, BIJUVA and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands (collectively, the "Licensed Products") in the United States and its possessions and territories, (ii) assigned to Mayne Pharma its exclusive license to commercialize ANNOVERA (together with the Licensed Products, collectively, the "Products") in the United States and its possessions and territories.